Fingolimod in active multiple sclerosis: an impressive decrease in Gd-enhancing lesions

BACKGROUND: Fingolimod is a disease modifying therapy (DMT) in highly active relapsing remitting multiple sclerosis (RRMS), as is natalizumab. Fingolimod decreases annual relapse rates and gadolinium enhancing lesions on MRI as compared to either interferon beta (IFNβ) or placebo. The effect of fing...

Descripción completa

Detalles Bibliográficos
Autores principales: Muris, Anne-Hilde, Rolf, Linda, Damoiseaux, Jan, Koeman, Ellen, Hupperts, Raymond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236684/
https://www.ncbi.nlm.nih.gov/pubmed/25138918
http://dx.doi.org/10.1186/s12883-014-0164-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236684/
https://www.ncbi.nlm.nih.gov/pubmed/25138918
http://dx.doi.org/10.1186/s12883-014-0164-5

Ejemplares similares